Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of aminocamptothecin in treating patients
with locally advanced, metastatic, or recurrent cancer of the stomach or esophagus.